Cargando…
Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation
The 78-kDa glucose-regulated protein (Grp78) is stress-inducible chaperone that mostly reside in the endoplasmic reticulum. Grp78 has been described to be released at times of cellular stress and as having extracellular properties that are anti-inflammatory or favor the resolution of inflammation. A...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131008/ https://www.ncbi.nlm.nih.gov/pubmed/27990144 http://dx.doi.org/10.3389/fimmu.2016.00552 |
_version_ | 1782470813994188800 |
---|---|
author | Yang, Muyang Zhang, Fan Qin, Kai Wu, Min Li, Heli Zhu, Huifen Ning, Qin Lei, Ping Shen, Guanxin |
author_facet | Yang, Muyang Zhang, Fan Qin, Kai Wu, Min Li, Heli Zhu, Huifen Ning, Qin Lei, Ping Shen, Guanxin |
author_sort | Yang, Muyang |
collection | PubMed |
description | The 78-kDa glucose-regulated protein (Grp78) is stress-inducible chaperone that mostly reside in the endoplasmic reticulum. Grp78 has been described to be released at times of cellular stress and as having extracellular properties that are anti-inflammatory or favor the resolution of inflammation. As antigen-presenting cells (APCs) play a critical role in both the priming of adaptive immune responses and the induction of self-tolerance, herein, we investigated the effect of Grp78 on the maturation of murine myeloid APCs (CD11c(+) cells). Results showed that CD11c(+) cells could be bound by AF488-labeled Grp78 and that Grp78 treatment induced a tolerogenic phenotype comparable to immature cells. Furthermore, when exposed to lipopolysaccharide, Grp78-treated CD11c(+) cells (DC(Grp78)) did not adopt a mature dendritic cell phenotype. DC(Grp78)-primed T cells exhibited reduced proliferation along with a concomitant expansion of CD4(+)CD25(+)FoxP3(+) cells in pancreaticoduodenal lymph nodes and induction of T cell apoptosis in vitro and ex vivo. The above work suggests that Grp78 is an immunomodulatory molecule that could aid resolution of inflammation. It may thus contribute to induce durable tolerance to be of potential therapeutic benefit in transplanted allogeneic grafts and autoimmune diseases such as type I diabetes. |
format | Online Article Text |
id | pubmed-5131008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51310082016-12-16 Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation Yang, Muyang Zhang, Fan Qin, Kai Wu, Min Li, Heli Zhu, Huifen Ning, Qin Lei, Ping Shen, Guanxin Front Immunol Immunology The 78-kDa glucose-regulated protein (Grp78) is stress-inducible chaperone that mostly reside in the endoplasmic reticulum. Grp78 has been described to be released at times of cellular stress and as having extracellular properties that are anti-inflammatory or favor the resolution of inflammation. As antigen-presenting cells (APCs) play a critical role in both the priming of adaptive immune responses and the induction of self-tolerance, herein, we investigated the effect of Grp78 on the maturation of murine myeloid APCs (CD11c(+) cells). Results showed that CD11c(+) cells could be bound by AF488-labeled Grp78 and that Grp78 treatment induced a tolerogenic phenotype comparable to immature cells. Furthermore, when exposed to lipopolysaccharide, Grp78-treated CD11c(+) cells (DC(Grp78)) did not adopt a mature dendritic cell phenotype. DC(Grp78)-primed T cells exhibited reduced proliferation along with a concomitant expansion of CD4(+)CD25(+)FoxP3(+) cells in pancreaticoduodenal lymph nodes and induction of T cell apoptosis in vitro and ex vivo. The above work suggests that Grp78 is an immunomodulatory molecule that could aid resolution of inflammation. It may thus contribute to induce durable tolerance to be of potential therapeutic benefit in transplanted allogeneic grafts and autoimmune diseases such as type I diabetes. Frontiers Media S.A. 2016-12-01 /pmc/articles/PMC5131008/ /pubmed/27990144 http://dx.doi.org/10.3389/fimmu.2016.00552 Text en Copyright © 2016 Yang, Zhang, Qin, Wu, Li, Zhu, Ning, Lei and Shen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yang, Muyang Zhang, Fan Qin, Kai Wu, Min Li, Heli Zhu, Huifen Ning, Qin Lei, Ping Shen, Guanxin Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation |
title | Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation |
title_full | Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation |
title_fullStr | Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation |
title_full_unstemmed | Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation |
title_short | Glucose-Regulated Protein 78-Induced Myeloid Antigen-Presenting Cells Maintained Tolerogenic Signature upon LPS Stimulation |
title_sort | glucose-regulated protein 78-induced myeloid antigen-presenting cells maintained tolerogenic signature upon lps stimulation |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131008/ https://www.ncbi.nlm.nih.gov/pubmed/27990144 http://dx.doi.org/10.3389/fimmu.2016.00552 |
work_keys_str_mv | AT yangmuyang glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT zhangfan glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT qinkai glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT wumin glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT liheli glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT zhuhuifen glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT ningqin glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT leiping glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation AT shenguanxin glucoseregulatedprotein78inducedmyeloidantigenpresentingcellsmaintainedtolerogenicsignatureuponlpsstimulation |